346
Views
1
CrossRef citations to date
0
Altmetric
Brief Report

CRISPR/cas9 cassette targeting Escherichia coliblaCTX-M specific gene of mastitis cow milk origin can alter the antibiotic resistant phenotype for cefotaxime

, &
 

Abstract

CTX-M beta-lactamases are one of the most important extended spectrum beta-lactamase (ESBL) resistance enzymes found in E. coli. In the present study, 59% of E. coli isolates from mastitis cow milk were reported to be positive for ESBL types. The prevalence of beta-lactam (β-lactam) antibiotic resistance was reported to be 84%, 72.7%, 52.27%, 50%, and 45.4% for cefotaxime, cefepime, cefuroxime, oxacillin, and cephalexine, respectively. The blaCTX-M gene was found in 65% (n = 17) of the E. coli isolates when they were genotyped. Further, the use of a CRISPR/cas9 cassette to target the E. coli blaCTX-M gene revealed changes in antibiotic phenotypes for cefotaxime.

Acknowledgements

The authors are thankful to Director, ICAR-National Dairy Research Institute, Karnal, Haryana, India for providing the necessary facilities to conduct the experiment.

Disclosure statement

We declare that none of the authors have any conflict of interest for the present study.

Additional information

Funding

The authors acknowledge the financial support received from the Indian Council of Agricultural Research, New Delhi, India as ICAR-Post Doctoral Fellowship to RD during this study period. The authors are also thankful to Science and Engineering Research Board, Department of Science and Technology, Government of India for the financial assistant to SD for the ongoing project code [EMR/2017/004602].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.